GGrantIndex
Sort

15,273 grants matching antimicrobial resistance

GENE EXPRESSION OF P AERUGINOSA DURING BIOFILM DEVELOPME

$226,420
Montana State University (Bozeman) · R01 · FY2003 · AI

Ultra Rapid Monitoring of Bacterial Nano-Growth and Antibiotic Susceptibility

$226,417
Raoul Kopelman · University Of Michigan At Ann Arbor · R21 · FY2009 · EB

Expanding small molecule functional metagenomics through shuttle BAC expression i

$226,401
Chengcang Charles Wu · Lucigen Corporation · R43 · FY2011 · AI

Characterization of F. tularensis Virulence Genes

$226,366
University Of Texas San Antonio · P01 · FY2005 · AI

N-terminal acylation and sorting of Helicobacter pylori lipoproteins and their role in host response to infection

$226,300
Mark S McClain · Vanderbilt University Medical Center · R21 · FY2022 · AI

Elucidating the within- and between-host adaptations driving S. aureus persistence within the bladder of long-term catheterized individuals

$226,253
Jennifer Nicole Walker · University Of Texas Hlth Sci Ctr Houston · R03 · FY2025 · DK

Planning an antibiotic duration trial for acute graft pyelonephritis after kidney transplantation

$226,219
David Van Duin · Univ Of North Carolina Chapel Hill · R34 · FY2023 · AI

GENE EXPRESSION OF P AERUGINOSA DURING BIOFILM DEVELOPME

$226,106
Montana State University (Bozeman) · R01 · FY2000 · AI

The critical roles of (p)ppGpp in homeostasis and antibiotic tolerance in Gram positive bacteria

$226,053
Jue D. Wang · University Of Wisconsin-Madison · R35 · FY2018 · GM

Function of the Vibrio cholerae RND efflux systems

$225,908
James Edward Bina · University Of Pittsburgh At Pittsburgh · R21 · FY2020 · AI

Vaccine induction of Salmonella-specific Th1 memory cells

$225,839
Stephen J McSorley · University Of California At Davis · R21 · FY2024 · AI

Dual mechanism thiopeptide analogs for TB drug development

$225,800
Miriam S. Braunstein · Univ Of North Carolina Chapel Hill · R21 · FY2019 · AI

Solid-state NMR studies of antimicrobial peptides

$225,798
Iowa State University · R01 · FY2003 · GM

Engagement of the macrophage integrated stress response in Salmonella infection

$225,758
Mary O'Riordan · University Of Michigan At Ann Arbor · R21 · FY2024 · AI

Cell separation in Neisseria gonorrhoeae

$225,750
Joseph P. Dillard · University Of Wisconsin-Madison · R21 · FY2013 · AI

Laser-Activated Nanoglues for the prevention and control of surgical site infections

$225,670
Kaushal Rege · Arizona State University-Tempe Campus · R21 · FY2021 · AI

Isoindolinones as Antimicrobial Agents

$225,624
Nigel D Priestley · Promiliad Biopharma, Inc. · R43 · FY2008 · AI

Mechanisms and implications of fosfomycin resistance in Escherichia coli

$225,600
Yohei Doi · University Of Pittsburgh At Pittsburgh · R21 · FY2016 · AI

Differences in infecting and colonizing Enterobacteriaceae from short-course vs s

$225,557
Scott J Weissman · Seattle Children'S Hospital · R21 · FY2013 · AI

New Tools for the interpretation of Pathogen Genomic Data with a focus on Mycobacterium tuberculosis

$225,549
Maha Farhat · Harvard Medical School · K01 · FY2017 · ES

Improving Anopheline fitness and resistance through fat body insulin signaling

$225,416
Michael Allen Riehle · University Of Arizona · R21 · FY2017 · AI

Novel QcrB Inhibitors for the Treatment of Tuberculosis

$225,343
Philip Arthur Hipskind · Lgenia, Inc. · R41 · FY2020 · AI

Orthogonal Approaches to Understanding the Role of PASTA Kinases in beta-lactam Resistance

$225,325
John-Demian Sauer · University Of Wisconsin-Madison · R21 · FY2019 · AI

ABC transporter-mediated secretion of capsular polysaccharides

$225,215
Jochen Zimmer · University Of Virginia · R21 · FY2021 · AI

A Novel Screen for Antibacterials that Are Non-Toxic to Mammals

$225,203
Corrella Detweiler · University Of Colorado · R21 · FY2017 · AI